115 related articles for article (PubMed ID: 38809765)
1. Lipidomic analysis of serum exosomes identifies a novel diagnostic marker for type 2 diabetes mellitus.
Zhang L; Lu T; Zhou B; Sun Y; Wang L; Qiao G; Yang T
Lab Med; 2024 May; ():. PubMed ID: 38809765
[TBL] [Abstract][Full Text] [Related]
2. Combined untargeted and targeted lipidomics approaches reveal potential biomarkers in type 2 diabetes mellitus cynomolgus monkeys.
Tian CY; Yang QH; Lv HZ; Yue F; Zhou FF
J Med Primatol; 2024 Feb; 53(1):e12688. PubMed ID: 38083989
[TBL] [Abstract][Full Text] [Related]
3. Lipidomic studies revealing serological markers associated with the occurrence of retinopathy in type 2 diabetes.
He M; Hou G; Liu M; Peng Z; Guo H; Wang Y; Sui J; Liu H; Yin X; Zhang M; Chen Z; Rensen PCN; Lin L; Wang Y; Shi B
J Transl Med; 2024 May; 22(1):448. PubMed ID: 38741137
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer.
Tao L; Zhou J; Yuan C; Zhang L; Li D; Si D; Xiu D; Zhong L
Metabolomics; 2019 May; 15(6):86. PubMed ID: 31147790
[TBL] [Abstract][Full Text] [Related]
5. Altered neopterin and IDO in kynurenine metabolism based on LC-MS/MS metabolomics study: Novel therapeutic checkpoints for type 2 diabetes mellitus.
Liu Z; Ma Z; Jin L; Nizhamuding X; Zeng J; Zhang T; Zhang J; Wang J; Zhao H; Zhou W; Zhang C
Clin Chim Acta; 2024 Apr; 557():117859. PubMed ID: 38518968
[TBL] [Abstract][Full Text] [Related]
6. [Lipid metabolomic analysis in exosomes of osteonecrosis of the femoral head based on ultra performance liquid chromatography-tandem mass spectrometry].
Guo M; Zhang J
Se Pu; 2022 Feb; 40(2):123-129. PubMed ID: 35080158
[TBL] [Abstract][Full Text] [Related]
7. Lipidomics based on UHPLC/Q-TOF-MS to characterize lipid metabolic profiling in patients with newly diagnosed type 2 diabetes mellitus with dyslipidemia.
Zhong X; Xiao C; Wang R; Deng Y; Du T; Li W; Zhong Y; Tan Y
Heliyon; 2024 Feb; 10(4):e26326. PubMed ID: 38404868
[TBL] [Abstract][Full Text] [Related]
8. Serum lipidomics profiles reveal potential lipid markers for prediabetes and type 2 diabetes in patients from multiple communities.
Xuan Q; Hu C; Zhang Y; Wang Q; Zhao X; Liu X; Wang C; Jia W; Xu G
Front Endocrinol (Lausanne); 2022; 13():966823. PubMed ID: 36060983
[TBL] [Abstract][Full Text] [Related]
9. Fasting serum lipid and dehydroepiandrosterone sulfate as important metabolites for detecting isolated postchallenge diabetes: serum metabolomics via ultra-high-performance LC-MS.
Liu L; Wang M; Yang X; Bi M; Na L; Niu Y; Li Y; Sun C
Clin Chem; 2013 Sep; 59(9):1338-48. PubMed ID: 23620415
[TBL] [Abstract][Full Text] [Related]
10. LC-MS-Based Lipidomic Analysis of Serum Samples from Patients with Type 2 Diabetes Mellitus (T2DM).
Liu J; Bai L; Wang W; Song Y; Zhao W; Li Q; Wu Q
Dis Markers; 2022; 2022():5559470. PubMed ID: 35190756
[TBL] [Abstract][Full Text] [Related]
11. LC-MS-Based Untargeted Metabolomics Reveals Early Biomarkers in STZ-Induced Diabetic Rats With Cognitive Impairment.
Chen R; Zeng Y; Xiao W; Zhang L; Shu Y
Front Endocrinol (Lausanne); 2021; 12():665309. PubMed ID: 34276557
[TBL] [Abstract][Full Text] [Related]
12. Untargeted lipidomics analysis in women with morbid obesity and type 2 diabetes mellitus: A comprehensive study.
Bertran L; Capellades J; Abelló S; Aguilar C; Auguet T; Richart C
PLoS One; 2024; 19(5):e0303569. PubMed ID: 38743756
[TBL] [Abstract][Full Text] [Related]
13. Altered Caffeine Metabolism Is Associated With Recurrent Hypoglycemia in Type 2 Diabetes Mellitus: A UPLC-MS-Based Untargeted Metabolomics Study.
Lijing W; Sujie K; Linxi W; Lishan H; Liqin Q; Zhidong Z; Kejun W; Mengjun Z; Xiaoying L; Xiaohong L; Libin L
Front Endocrinol (Lausanne); 2022; 13():843556. PubMed ID: 35784552
[TBL] [Abstract][Full Text] [Related]
14. Preliminary serum and fecal metabolomics study of spontaneously diabetic cynomolgus monkeys based on LC-MS/MS.
Tian C; Qiu M; Lv H; Yue F; Zhou F
J Med Primatol; 2022 Dec; 51(6):355-366. PubMed ID: 35993379
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of coagulation pathway-related proteins in diabetic urine exosomes.
Liu T; Liu N; Wang Y; Li T; Zhang M
Cardiovasc Diabetol; 2023 Jun; 22(1):145. PubMed ID: 37349729
[TBL] [Abstract][Full Text] [Related]
16. Analysis of two intestinal bacterial metabolites (trimethylamine N-oxide and phenylacetylglutamine) in human serum samples of patients with T2DM and AMI using a liquid chromatography tandem mass spectrometry method.
Tang Y; Zou Y; Cui J; Ma X; Zhang L; Yu S; Qiu L
Clin Chim Acta; 2022 Nov; 536():162-168. PubMed ID: 36191613
[TBL] [Abstract][Full Text] [Related]
17. Correlation of asprosin and Nrg-4 with type 2 diabetes Mellitus Complicated with Coronary Heart Disease and the Diagnostic Value.
Zhong M; Tian X; Sun Q; Li L; Lu Y; Feng Z; Gao Y; Li S
BMC Endocr Disord; 2023 Mar; 23(1):61. PubMed ID: 36915073
[TBL] [Abstract][Full Text] [Related]
18. The Changes of Lipidomic Profiles Reveal Therapeutic Effects of Exenatide in Patients With Type 2 Diabetes.
Zhang L; Hu Y; An Y; Wang Q; Liu J; Wang G
Front Endocrinol (Lausanne); 2022; 13():677202. PubMed ID: 35432194
[TBL] [Abstract][Full Text] [Related]
19. 12,13-diHOME and noradrenaline are associated with the occurrence of acute myocardial infarction in patients with type 2 diabetes mellitus.
Cao N; Wang Y; Bao B; Wang M; Li J; Dang W; Hua B; Song L; Li H; Li W
Diabetol Metab Syndr; 2023 Jun; 15(1):142. PubMed ID: 37386486
[TBL] [Abstract][Full Text] [Related]
20. [Proteomic analysis of serum and serum exosomes, and their application in intrahepatic cholangiocarcinoma].
Yang K; Wang W; Wang Y; Yan C
Se Pu; 2021 Nov; 39(11):1191-1202. PubMed ID: 34677014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
